Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer: A comparison of treatment trends in the United States and Germany from 2004 to 2011

Radiotherapy and Oncology

Volumn 115, Issue 1, 2015, Pages 90-95

  Hager, Benjamin ^a   Kraywinkel, Klaus ^b   Keck, Bastian ^c   Katalinic, Alexander ^d   Meyer, Martin ^e   Zeissig, Sylke Ruth ^f   Stabenow, Roland ^g   Froehner, Michael ^a   Huber, Johannes ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e Population Based Cancer Registry   (Germany)

^f Cancer Registry of Rhineland Palatinate   (Germany)

^g Com Cancer Reg of the Fed States Berlin/Brandenburg/Mecklenburg Vorpommern/Sachsen Anhalt ^*  (Germany)

Author keywords

Health services research; Internationality; Physician's practice patterns; Prostatic neoplasms; SEER program

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CENTER; CANCER RADIOTHERAPY; CANCER REGISTRY; CONTROLLED STUDY; GERMANY; HEALTH CARE DISPARITY; HEALTH CARE UTILIZATION; HUMAN; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TREND STUDY; UNITED STATES; COMPARATIVE STUDY; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK FACTOR;

AGED; GERMANY; HUMANS; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS; UNITED STATES;

EID: 84930754474     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2015.02.024     Document Type: Article

References (31)

1. A. Heidenreich, P.J. Bastian, and J. Bellmunt EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013 Eur Urol 65 2014 124 137
2. J.A. Lane, F.C. Hamdy, R.M. Martin, E.L. Turner, D.E. Neal, and J.L. Donovan Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies Eur J Cancer 46 2010 3095 3101
3. T.J. Wilt, M.K. Brawer, and K.M. Jones Radical prostatectomy versus observation for localized prostate cancer N Engl J Med 367 2012 203 213
4. M. Stöckle, and R. Bussar-Maatz Z Evid Fortbild Qual Gesundhwes 106 2012 333 335 (discussion 5)
5. P.C. Walsh Re: radical prostatectomy versus observation for localized prostate cancer J Urol 188 2012 2225 2226
6. D.A. Kapoor, S.H. Zimberg, L.M. Ohrin, I. Underwood, I. Underwood Willie, and C.A. Olsson Utilization trends in prostate cancer therapy J Urol 186 2011 860 864
7. A.B. Jani, P.A.S. Johnstone, S.L. Liauw, V.A. Master, and P.J. Rossi Prostate cancer modality time trend analyses from 1973 to 2004: a Surveillance, Epidemiology, and End Results registry analysis Am J Clin Oncol 33 2010 168 172
8. E. Scosyrev, J. Messing, K. Noyes, P. Veazie, and E. Messing Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: An overview Urol Oncol 30 2012 126 132
9. E.C. Lau, F.S. Mowat, and M.A. Kelsh Use of electronic medical records (EMR) for oncology outcomes research: assessing the comparability of EMR information to patient registry and health claims data Clin Epidemiol 3 2011 259 272
10. J. Haberland, J. Bertz, U. Wolf, T. Ziese, and B.-M. Kurth German cancer statistics 2004 BMC Cancer 10 2010 52
11. K. Kraywinkel, B. Barnes, S. Dahm, J. Haberland, A. Nennecke, and R. Stabenow Nationwide statements from regional data: methods of the Center for Cancer Registry Data Article in German Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 57 2014 13 21
12. SEER. SEER program coding and staging manual. Coding guidelines prostate gland. 2013.
13. S.H. Giordano, Y.-F. Kuo, Z. Duan, G.N. Hortobagyi, J. Freeman, and J.S. Goodwin Limits of observational data in determining outcomes from cancer therapy Cancer 112 2008 2456 2466
14. G.S. Cooper, B. Virnig, C.N. Klabunde, N. Schussler, J. Freeman, and J.L. Warren Use of SEER-Medicare data for measuring cancer surgery Med Care 40 IV 2002 43 48
15. M.R. Cooperberg, J.M. Broering, P.W. Kantoff, and P.R. Carroll Contemporary trends in low risk prostate cancer: risk assessment and treatment J Urol 178 2007 S14 S19
16. M.J. Maurice, R. Abouassaly, and H. Zhu A population-based study of expectant management utilization and its predictors for low-risk prostate cancer J Clin Oncol 32 2014 (suppl 4; abstr 68)
17. R.G. Middleton, I.M. Thompson, and M.S. Austenfeld Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer. The American Urological Association J Urol 154 1995 2144 2148
18. I. Thompson, J.B. Thrasher, and G. Aus Guideline for the management of clinically localized prostate cancer: 2007 update J Urol 177 2007 2106 2131
19. Wirth M, Weißbach L, Ackermann R, et al. Interdisciplinary guideline of quality S3 for early detection, diagnosis and treatment of different stages of prostate cancer. (Guideline in German). 2011.
20. Weißbach L, Schaefer C, Heidenreich A. A paradigm shift. Defensive strategies for the treatment of localized prostate cancer in the new S3 guideline [Article in German]. Urologe A 2010;49:199-205.
21. B.P. Falit, C.P. Gross, and K.B. Roberts Integrated prostate cancer centers and over-utilization of IMRT: a close look at fee-for-service medicine in radiation oncology Int J Radiat Oncol Biol Phys 76 2010 1285 1288
22. J.E. Bekelman, G. Suneja, T. Guzzo, C.E. Pollack, K. Armstrong, and A.J. Epstein Effect of practice integration between urologists and radiation oncologists on prostate cancer treatment patterns J Urol 190 2013 97 101
23. S.L. Chang, A.S. Kibel, J.D. Brooks, and B.I. Chung The impact of robotic surgery on the surgical management of prostate cancer in the USA BJU Int 2014
24. T.L. Jang, J.E. Bekelman, and Y. Liu Physician visits prior to treatment for clinically localized prostate cancer Arch Intern Med 170 2010 440 450
25. C.E. Pollack, G. Weissman, J. Bekelman, K. Liao, and K. Armstrong Physician social networks and variation in prostate cancer treatment in three cities Health Serv Res 47 2012 380 403
26. S. Houterman, M.L. Janssen-Heijnen, C.D. Verheij, P.J. Kil, H.A. van den Berg, and J.W. Coebergh Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: an in-depth population-based study Prostate Cancer Prostatic Dis 9 2006 179 184
27. M. de Camargo Cancela, H. Comber, and L. Sharp Age remains the major predictor of curative treatment non-receipt for localised prostate cancer: a population-based study Br J Cancer 109 2013 272 279
28. A.S. Hamilton, P.C. Albertsen, and T.K. Johnson Trends in the treatment of localized prostate cancer using supplemented cancer registry data BJU Int 107 2011 576 584
29. T.J. Daskivich, J. Lai, and A.W. Dick Comparative effectiveness of aggressive versus nonaggressive treatment among men with early-stage prostate cancer and differing comorbid disease burdens at diagnosis Cancer 2014
30. M. Froehner, A.-E. Kellner, R. Koch, G.B. Baretton, O.W. Hakenberg, and M.P. Wirth A combined index to classify prognostic comorbidity in candidates for radical prostatectomy BMC Urol 14 2014 1 8
31. B.D. Sommers, C.J. Beard, A.V. D'Amico, I. Kaplan, J.P. Richie, and R.J. Zeckhauser Predictors of patient preferences and treatment choices for localized prostate cancer Cancer 113 2008 2058 2067